Merck (MRK.US) stock jumped over 9% during today's session after drugmaker announced its new antiviral drug molnupiravir lower the risk of death or hospitalization by 50% for Covid patients. Experts say antiviral pills could be the last tool needed to beat back Covid-19.
Only 7.3% of patients who took the pill were hospitalized according to Phase 3 study results and none of them died. Meanwhile 14.1% of placebo recipients had to be hospitalized. Eight patients in the placebo group died. The pharmaceutical company plans to file for emergency use authorization. Today's news negatively affected other pharma-giants stocks. Pfizer-partner BioNTech (BNTX.US) and Novavax (NVAX.US) at one point fell 13% and 18%, respectively.
เริ่มเทรดทันทีวันนี้ หรือ ลองใช้บัญชีทดลองแบบไร้ความเสี่ยง
เปิดบัญชี ลองบัญชีเดโม่ ดาวน์โหลดแอปมือถือ ดาวน์โหลดแอปมือถือ
Merck (MRK.US) stock launched today's session sharply higher and broke above the lower limit of the triangle formation. Currently price is testing major resistance at $83.80 which is marked with upper limit of the 1:1 structure and 78.6% Fibonacci retracement of the last downward wave. Should a break higher occur, then the upward move may accelerate towards resistance at $ 88.27. However, if sellers will manage to halt advances here, then another downward impulse towards support at $78.35 may be launched. Source: xStation5
